HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect
Authors:
- Khaled GreishKhaled Greish
- Haibo QinHQHaibo Qin
- Long LiaoLLLong Liao
- Hideaki NakamuraHNHideaki Nakamura
- Motohiro TakeyaMTMotohiro Takeya
- Hiroshi MaedaHMHiroshi Maeda
- 1 August 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 81 (3) , 540-547
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course studyThe Journal of Nutritional Biochemistry, 2009
- Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosisExperimental Hematology, 2008
- The Involvement of Bax in Zinc-Induced Mitochondrial Apoptogenesis in Malignant Prostate CellsMolecular Cancer, 2008
- Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinibBlood, 2008
- Oxystress inducing antitumor therapeutics via tumor‐targeted delivery of PEG‐conjugated D‐amino acid oxidaseInternational Journal of Cancer, 2007
- High-loading nanosized micelles of copoly(styrene–maleic acid)–zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitorBiomaterials, 2007
- Identification of Heme Oxygenase-1 As a Novel BCR/ABL-Dependent Survival Factor in Chronic Myeloid LeukemiaCancer Research, 2004
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Macromolecular TherapeuticsClinical Pharmacokinetics, 2003
- Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding LigandJournal of Bioactive and Compatible Polymers, 1988